Completed NA INTERVENTIONAL 1-arm NCT04704258

NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device (NAUTILUS)

Clinical Study of a Novel Transcatheter Anti-embolic Filter (FLOWer) for Cerebral Protection During Aortic Valve Interventions

Sponsor: AorticLab Srl

Conditions Aortic Valve Stenosis Intracranial Embolism and Thrombosis

Interventions FLOWer Embolic Protection System TAVI (Transcatheter Aortic Valve Implant)

Updated 7 times since 2021 Last updated: Feb 22, 2024 Started: May 3, 2021 Primary completion: Jun 6, 2023 Completion: Jun 6, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Aortic Valve Stenosis and Intracranial Embolism and Thrombosis and is currently completed. AorticLab Srl leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Mar 2023 — Mar 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Sep 2022 — Mar 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2021 — Sep 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AorticLab Srl
Meditrial Europe Ltd.

Data source: AorticLab Srl

For direct contact, visit the study record on ClinicalTrials.gov .

NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device (NAUTILUS)

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials